• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌:原发肿瘤大小与转移扩散概率之间的关系

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination.

作者信息

Koscielny S, Tubiana M, Lê M G, Valleron A J, Mouriesse H, Contesso G, Sarrazin D

出版信息

Br J Cancer. 1984 Jun;49(6):709-15. doi: 10.1038/bjc.1984.112.

DOI:10.1038/bjc.1984.112
PMID:6733019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1976833/
Abstract

The relationship between the size of the primary tumour upon initial treatment and the incidence of distant metastasis during the course of the disease was investigated using data from 2648 breast cancers treated at the Institut Gustave Roussy between 1954 and 1972. This analysis suggests the existence for each tumour of a critical volume (threshold) at which the first remote metastasis is initiated. The correlation between the size of the primary tumour and the probability of metastatic dissemination was assessed as well as the influence on this correlation of two prognostic indicators: histological grade and number of involved lymph nodes. It was found that the threshold volume is strongly correlated with the number of involved lymph nodes and the histological grading.

摘要

利用1954年至1972年间在古斯塔夫·鲁西研究所接受治疗的2648例乳腺癌数据,研究了初始治疗时原发肿瘤大小与疾病过程中远处转移发生率之间的关系。该分析表明,每种肿瘤都存在一个临界体积(阈值),在这个体积时首次发生远处转移。评估了原发肿瘤大小与转移扩散概率之间的相关性,以及两个预后指标(组织学分级和受累淋巴结数量)对这种相关性的影响。结果发现,临界体积与受累淋巴结数量和组织学分级密切相关。

相似文献

1
Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination.乳腺癌:原发肿瘤大小与转移扩散概率之间的关系
Br J Cancer. 1984 Jun;49(6):709-15. doi: 10.1038/bjc.1984.112.
2
[Natural history of human cancer and prognostic factors. The example of breast cancer].[人类癌症的自然史及预后因素。以乳腺癌为例]
Bull Cancer. 1987;74(1):43-57.
3
Natural history of human breast cancer: recent data and clinical implications.人类乳腺癌的自然史:最新数据及临床意义
Breast Cancer Res Treat. 1991 Aug;18(3):125-40. doi: 10.1007/BF01990028.
4
The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases.人类乳腺癌的自然病史。腋窝淋巴结受累与远处转移起始之间的关系。
Br J Cancer. 1989 May;59(5):775-82. doi: 10.1038/bjc.1989.162.
5
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.影响乳腺癌骨转移发生的临床参数评估
BMC Cancer. 2016 May 12;16:307. doi: 10.1186/s12885-016-2345-7.
6
Impact of tumour size on axillary involvement and distant dissemination in breast cancer.肿瘤大小对乳腺癌腋窝受累及远处转移的影响。
Br J Cancer. 2009 Sep 15;101(6):902-7. doi: 10.1038/sj.bjc.6605221. Epub 2009 Aug 18.
7
The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.肿瘤大小、淋巴结状态和远处转移之间的关系:乳腺癌的起源。
Breast Cancer Res Treat. 2018 Aug;170(3):647-656. doi: 10.1007/s10549-018-4796-9. Epub 2018 Apr 24.
8
Prediction of the long-term survival in breast cancer patients according to the present oncological status.根据目前的肿瘤学状况预测乳腺癌患者的长期生存率。
Stat Med. 2002 Aug 30;21(16):2345-54. doi: 10.1002/sim.1046.
9
The quotient of number of nodes and tumour size (N/T) from primary breast cancer predicts the clinical course after diagnosis of distant relapse.原发性乳腺癌的淋巴结数量与肿瘤大小的比值(N/T)可预测远处复发诊断后的临床病程。
Eur J Surg Oncol. 2004 Apr;30(3):346-51. doi: 10.1016/j.ejso.2003.10.006.
10
The natural history of breast cancer: implications for a screening strategy.乳腺癌的自然史:对筛查策略的影响。
Int J Radiat Oncol Biol Phys. 1990 Nov;19(5):1117-20. doi: 10.1016/0360-3016(90)90213-4.

引用本文的文献

1
Relationships Between Breast Edema and Axillary Lymph Node Metastasis in Breast Cancer.乳腺癌中乳腺水肿与腋窝淋巴结转移的关系
Diagnostics (Basel). 2025 May 22;15(11):1300. doi: 10.3390/diagnostics15111300.
2
A stochastic modelling framework for cancer patient trajectories: combining tumour growth, metastasis, and survival.一种用于癌症患者病程的随机建模框架:结合肿瘤生长、转移和生存情况。
J Math Biol. 2025 May 22;90(6):65. doi: 10.1007/s00285-025-02229-6.
3
Assessment of Clinicopathological Response to Neoadjuvant Chemotherapy in Patients Diagnosed With Locally Advanced Breast Carcinoma.局部晚期乳腺癌患者新辅助化疗的临床病理反应评估
Cureus. 2025 Apr 11;17(4):e82057. doi: 10.7759/cureus.82057. eCollection 2025 Apr.
4
Very Low Internal Echoes With Enhanced Posterior Echoes Suggest the Aggressive Nature of Expanding Ovoid Breast Cancers: A Case Report.极低内部回声伴后方回声增强提示椭圆形乳腺浸润性癌的侵袭性:病例报告
Cureus. 2025 Jan 26;17(1):e78014. doi: 10.7759/cureus.78014. eCollection 2025 Jan.
5
3T-MRI Artificial Intelligence in Patients with Invasive Breast Cancer to Predict Distant Metastasis Status: A Pilot Study.3T磁共振成像人工智能技术用于预测浸润性乳腺癌患者远处转移状态的初步研究
Cancers (Basel). 2022 Dec 21;15(1):36. doi: 10.3390/cancers15010036.
6
Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer.用于预测临床高危乳腺癌女性MammaPrint结果低风险概率的列线图的验证研究
Discov Oncol. 2022 Dec 23;13(1):141. doi: 10.1007/s12672-022-00604-z.
7
Volume Index is a Risk Factor for Recurrence Even in Patients with Clinical Stage IA Endometrial Cancer Undergoing either Laparotomy or Laparoscopy: A Retrospective Study.即使对于接受剖腹手术或腹腔镜手术的临床IA期子宫内膜癌患者,体积指数也是复发的一个危险因素:一项回顾性研究。
Gynecol Minim Invasive Ther. 2022 May 4;11(2):94-99. doi: 10.4103/GMIT.GMIT_12_21. eCollection 2022 Apr-Jun.
8
Breast cancer microenvironment and obesity: challenges for therapy.乳腺癌微环境与肥胖:治疗面临的挑战。
Cancer Metastasis Rev. 2022 Sep;41(3):627-647. doi: 10.1007/s10555-022-10031-9. Epub 2022 Apr 18.
9
Inositol (1,4,5)-Trisphosphate Receptors in Invasive Breast Cancer: A New Prognostic Tool?三磷酸肌醇受体在浸润性乳腺癌中的作用:一种新的预后工具?
Int J Mol Sci. 2022 Mar 9;23(6):2962. doi: 10.3390/ijms23062962.
10
A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer.用于预测临床高风险乳腺癌女性中 MammaPrint 检测低风险概率的列线图。
Sci Rep. 2021 Dec 6;11(1):23509. doi: 10.1038/s41598-021-02992-8.

本文引用的文献

1
Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.乳腺癌的组织学分级与预后;对1409例病例的研究,其中359例已随访15年。
Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.
2
Observations on growth rates of human tumors.关于人类肿瘤生长速率的观察
Am J Roentgenol Radium Ther Nucl Med. 1956 Nov;76(5):988-1000.
3
Kinetic parameters and the course of the disease in breast cancer.乳腺癌的动力学参数与疾病进程
Cancer. 1981 Mar 1;47(5):937-43. doi: 10.1002/1097-0142(19810301)47:5<937::aid-cncr2820470520>3.0.co;2-6.
4
Ten- to fourteen-year effect of screening on breast cancer mortality.筛查对乳腺癌死亡率的10至14年影响。
J Natl Cancer Inst. 1982 Aug;69(2):349-55.
5
L.H. Gray Medal lecture: cell kinetics and radiation oncology.L.H. 格雷奖章讲座:细胞动力学与放射肿瘤学
Int J Radiat Oncol Biol Phys. 1982 Sep;8(9):1471-89. doi: 10.1016/0360-3016(82)90607-1.
6
Factors influencing short and long term survival of breast cancer patients.影响乳腺癌患者短期和长期生存的因素。
Surg Gynecol Obstet. 1966 Jun;122(6):1311-6.
7
[Age of metastatic adenopathies in breast cancer].[乳腺癌转移性淋巴结病的年龄]
Ann Anat Pathol (Paris). 1968 Oct-Dec;13(4):449-59.
8
Cancer of the breast: size of neoplasm and prognosis.乳腺癌:肿瘤大小与预后
Cancer. 1969 Nov;24(5):1071-80. doi: 10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h.
9
Relation between the pathological nature and the growth rate of human tumors.人类肿瘤的病理性质与生长速率之间的关系。
Eur J Cancer (1965). 1971 Aug;7(4):307-15. doi: 10.1016/0014-2964(71)90073-9.
10
[Growth rate and natural history of breast cancer].[乳腺癌的生长速率及自然病史]
Bull Cancer. 1975 Oct-Dec;62(4):341-58.